MX2025004633A - 1,3,5-triazinas 2,4,6-trisustituidas como moduladores del receptor 1 de quimiocina con motivo cx3c (cx3cr1) - Google Patents

1,3,5-triazinas 2,4,6-trisustituidas como moduladores del receptor 1 de quimiocina con motivo cx3c (cx3cr1)

Info

Publication number
MX2025004633A
MX2025004633A MX2025004633A MX2025004633A MX2025004633A MX 2025004633 A MX2025004633 A MX 2025004633A MX 2025004633 A MX2025004633 A MX 2025004633A MX 2025004633 A MX2025004633 A MX 2025004633A MX 2025004633 A MX2025004633 A MX 2025004633A
Authority
MX
Mexico
Prior art keywords
sub
trisubstituted
modulators
triazines
compounds
Prior art date
Application number
MX2025004633A
Other languages
English (en)
Inventor
Karolina Nilsson
Martin Bauer
Ölwegård-Halvarsson Maria
Mikael Brink
Jon Paul Janet
Fredrik Bergstrom
Mateusz Piotr Plesniak
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MX2025004633A publication Critical patent/MX2025004633A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/08—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen ciertos compuestos 1,3,5-triazina 2,4,6 trisustituidos de la Fórmula (I), (I) y sales farmacéuticamente aceptables de estos, junto con composiciones que los contienen y su uso en terapia. Los compuestos son moduladores de CX3CR1 y de esta manera son particularmente útiles en el tratamiento o profilaxis de trastornos cardiovasculares tales como miocardiopatía dilatada no isquémica e insuficiencia cardíaca.
MX2025004633A 2022-10-19 2025-04-21 1,3,5-triazinas 2,4,6-trisustituidas como moduladores del receptor 1 de quimiocina con motivo cx3c (cx3cr1) MX2025004633A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263417472P 2022-10-19 2022-10-19
PCT/EP2023/079035 WO2024083933A1 (en) 2022-10-19 2023-10-18 2,4,6-trisubstituted 1,3,5-triazines as modulators of cx 3cr1

Publications (1)

Publication Number Publication Date
MX2025004633A true MX2025004633A (es) 2025-06-02

Family

ID=88511235

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025004633A MX2025004633A (es) 2022-10-19 2025-04-21 1,3,5-triazinas 2,4,6-trisustituidas como moduladores del receptor 1 de quimiocina con motivo cx3c (cx3cr1)

Country Status (17)

Country Link
US (2) US20240199558A1 (es)
EP (1) EP4605388A1 (es)
JP (1) JP2025537492A (es)
KR (1) KR20250086780A (es)
CN (1) CN120077035A (es)
AR (1) AR130808A1 (es)
AU (1) AU2023362450A1 (es)
CL (1) CL2025001155A1 (es)
CO (1) CO2025006339A2 (es)
CR (1) CR20250196A (es)
DO (1) DOP2025000096A (es)
IL (1) IL320305A (es)
MX (1) MX2025004633A (es)
PE (1) PE20251587A1 (es)
TW (1) TW202430188A (es)
UY (1) UY40495A (es)
WO (1) WO2024083933A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20251587A1 (es) * 2022-10-19 2025-06-16 Astrazeneca Ab 1,3,5-triazinas 2,4,6-trisustituidas como modulares de cx3cr1
WO2025219939A1 (en) * 2024-04-17 2025-10-23 Astrazeneca Ab Salts and polymorphs of cx3cr1 modulators
WO2025219950A1 (en) * 2024-04-18 2025-10-23 Astrazeneca Ab Small molecule cx3cr1 modulators

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19960683A1 (de) * 1999-12-15 2001-08-23 Aventis Cropscience Gmbh Substituierte 2,4-Diamino-1,3,5-triazine, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
SE0101082D0 (sv) 2001-03-27 2001-03-27 Astrazeneca Ab Novel use
WO2005033115A1 (en) 2003-10-07 2005-04-14 Astrazeneca Ab New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1
GB0401269D0 (en) 2004-01-21 2004-02-25 Astrazeneca Ab Compounds
AR053347A1 (es) 2005-04-06 2007-05-02 Astrazeneca Ab Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos
UA90707C2 (en) 2005-04-06 2010-05-25 Астразенека Аб Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives
CN101522693B (zh) 2006-09-29 2012-01-04 阿斯利康(瑞典)有限公司 5,7-二取代的[1,3]噻唑并[4,5-d]嘧啶-2(3h)-胺衍生物和它们在治疗中的用途
TW200820973A (en) 2006-09-29 2008-05-16 Astrazeneca Ab Novel compounds 480
AR071036A1 (es) 2008-03-26 2010-05-19 Astrazeneca Ab Derivados 5, 7-disustituidos de [1, 3]tiazolo[4, 5-d]pirimidin-2 (3h)-ona, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por el receptor cx3cr1.
TWI543975B (zh) 2011-09-13 2016-08-01 Eisai R&D Man Co Ltd Pyrrolidin-3-yl acetic acid derivatives
EA201591291A1 (ru) 2013-01-08 2015-12-30 Савира Фармасьютикалз Гмбх Производные пиримидона и их применение в лечении, облегчении или профилактике вирусного заболевания
PE20251587A1 (es) * 2022-10-19 2025-06-16 Astrazeneca Ab 1,3,5-triazinas 2,4,6-trisustituidas como modulares de cx3cr1

Also Published As

Publication number Publication date
US20240199558A1 (en) 2024-06-20
UY40495A (es) 2024-05-15
AU2023362450A1 (en) 2025-05-29
IL320305A (en) 2025-06-01
US20240383866A1 (en) 2024-11-21
DOP2025000096A (es) 2025-07-15
TW202430188A (zh) 2024-08-01
US12404253B2 (en) 2025-09-02
CN120077035A (zh) 2025-05-30
CL2025001155A1 (es) 2025-08-29
CR20250196A (es) 2025-11-21
EP4605388A1 (en) 2025-08-27
AR130808A1 (es) 2025-01-22
WO2024083933A1 (en) 2024-04-25
PE20251587A1 (es) 2025-06-16
KR20250086780A (ko) 2025-06-13
JP2025537492A (ja) 2025-11-18
CO2025006339A2 (es) 2025-05-29

Similar Documents

Publication Publication Date Title
MX2022010011A (es) Inhibidores de prmt5 novedosos.
CR20230310A (es) Inhibidores de prmt5
MX2023009222A (es) Inhibidores tricíclicos-amido-bicíclicos de prmt5.
CO2025006339A2 (es) 1,3,5-triazinas 2,4,6-trisustituidas como moduladores de cx3cr1
MX2024013838A (es) Compuestos y usos de estos
MX2023004149A (es) Degradadores de moléculas pequeñas de piperidinilo de helios y procedimientos de uso.
CR20230566A (es) Derivados de triazina y su uso en el tratamiento del cáncer
PH12022553530A1 (en) 1'-cyano nucleoside analogs and uses thereof
GEAP202416135A (en) 2-oxoimidazolidine-4-carboxamides as nav1.8 inhibitors
MX2022005232A (es) Degradadores de moleculas peque?as de helios y procedimientos de uso.
EA202191801A1 (ru) Гетероциклические ингибиторы mat2a и способы применения для лечения рака
DK0611368T3 (da) Substituerede aminopyrimidiner som angiotensin II-antagonister
PH12020552004A1 (en) Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compound, and methods of use thereof
PH12022551767A1 (en) Sulfonimidamide compounds as nlrp3 modulators
MX2024004131A (es) Ciertos 2,5-diazabiciclo[4.2.0]octanos como moduladores del receptor de glp-1.
ES2060951T5 (es) Azaindenos.
MX2024011120A (es) Pirimidinas para degradar la tirosina cinasa de bruton.
MX2023009954A (es) Compuestos de aminopirimidina y métodos de uso de estos.
MX2025002166A (es) Compuestos y metodos para modular her2
MX2024007395A (es) Tetrahidropiridazinas, composiciones que las comprenden y usos de estas.
MX2024013842A (es) Benzoyparazina pirazinas y sus usos
GEAP202516820A (en) Prmt5-mta inhibitor
MX2025013649A (es) Compuesto de oxazolona sustituida para reducir los niveles de proteinas con dedos de zinc ikaros (ikzf) 1-4
MX2024000634A (es) Compuestos de sulfonimidamida y usos de los mismos.
WO2019202346A3 (en) Pharmaceutically effective compounds inhibiting selectively the myosin 2 isoforms